This disclosure relates to novel melatonin analogues or naphthyl(ethyl)acetamides, their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This disclosure also provides compositions comprising a compound of this disclosure and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a dual melatoninergic agonist and serotoninergic antagonist.
Spontaneous Hydrolysis Reactions of <i>cis</i>- and <i>trans</i>-β-Methyl-4-methoxystyrene Oxides (Anethole Oxides): Buildup of <i>trans</i>-Anethole Oxide as an Intermediate in the Spontaneous Reaction of <i>cis</i>-Anethole Oxide
作者:Ram S. Mohan、Kostas Gavardinas、Sampson Kyere、Dale L. Whalen
DOI:10.1021/jo991521b
日期:2000.3.1
primary products of the spontaneous reaction of 2 are (4-methoxyphenyl)acetone (73%) and threo-1-(4-methoxyphenyl)-1,2-propanediol (ca. 3%). The rates and products of the spontaneous reaction of 2 and its beta-deuterium-labeled derivative were determined, and the lack of significant kinetic and partitioning deuterium isotopeeffects indicates that the isomerization of 2 to ketone and to trans-anethole